Page last updated: 2024-08-23

buserelin and Triple Negative Breast Neoplasms

buserelin has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chan, C; Liu, K; Russo, M	1

Other Studies

1 other study(ies) available for buserelin and Triple Negative Breast Neoplasms

Article	Year
Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series. Reproductive biology and endocrinology : RB&E, 2020, Jun-05, Volume: 18, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Buserelin; Chorionic Gonadotropin; Cryopreservation; Female; Fertility Agents, Female; Fertility Preservation; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Letrozole; Luteal Phase; Luteinizing Hormone; Oocyte Retrieval; Ovulation Induction; Progesterone; Recombinant Proteins; Treatment Failure; Triple Negative Breast Neoplasms	2020

Article

Year

Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.

Reproductive biology and endocrinology : RB&E, 2020, Jun-05, Volume: 18, Issue:1

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Buserelin; Chorionic Gonadotropin; Cryopreservation; Female; Fertility Agents, Female; Fertility Preservation; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Letrozole; Luteal Phase; Luteinizing Hormone; Oocyte Retrieval; Ovulation Induction; Progesterone; Recombinant Proteins; Treatment Failure; Triple Negative Breast Neoplasms

2020